由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - 有没有人来分析下SNSS?
相关主题
aezs&snss【药股】ASCO 2010
是不是应该SHort EXEL大盘连跌两天,大家列一列手头还发绿的股票吧
大牛能否帮忙解读一下OXGN今天早上的新闻$$$$$6月7---6月11号选股大赛$$$$$$
CLDX 怎么瀑布到5块多了?推荐一个大家都很熟悉的股票
PSTI(转载)【选股大赛】0628-0702
我检讨。。。KevinsFather...any comment on SNSS?
明日关注【总结贴】KERX will release short term result of Zerenex tomorrow
KERX up 18% BHPPHM
相关话题的讨论汇总
话题: snss话题: vosaroxin话题: quarter话题: sunesis话题: march
1 (共1页)
j******s
发帖数: 30
1
ms最近开始有点上涨的趋势。。。不知道有没有行家来分析分析啊。。。
p********e
发帖数: 1960
2
去文学城的大千看看勃事后的分析吧...

【在 j******s 的大作中提到】
: ms最近开始有点上涨的趋势。。。不知道有没有行家来分析分析啊。。。
f**********g
发帖数: 2252
3
SNSS correction around 3. Not bad today.
Sunesis posts net income in Q1
45 minutes ago - DTM via Comtex
DatamonitorSunesis Pharmaceuticals, Inc., a developer of new oncology
therapeutics, has reported a net income of $1.84 million, or $0.04 per share
, for the first quarter ended March 31, 2011, compared to a net loss of $4.
65 million, or $0.65 per share, for the first quarter ended March 31, 2010.
For the first quarter of 2011, total revenues were $4 million, compared to $
13,000 for the first quarter of 2010.
"Since the beginning of the year, we have achieved a number of milestones
that enhance the prospects for vosaroxin, our lead program, as well as our
earlier-stage pipeline programs," said Daniel Swisher, CEO of Sunesis. "For
vosaroxin, we made progress on the clinical, regulatory and intellectual
property fronts: the roll-out of our Phase III pivotal Valor trial in
relapsed/refractory AML is progressing well, we received FDA Fast Track
designation for vosaroxin in AML and an important European patent has issued
."
L**j
发帖数: 948
4
snss 歇了。
1 (共1页)
相关主题
PPHMPSTI(转载)
新年献礼--我关注的生物,资源股及其它我检讨。。。
老牛...comments on SNSS, AEZS, BPAX明日关注【总结贴】
ZT; JASOKERX up 18% BH
aezs&snss【药股】ASCO 2010
是不是应该SHort EXEL大盘连跌两天,大家列一列手头还发绿的股票吧
大牛能否帮忙解读一下OXGN今天早上的新闻$$$$$6月7---6月11号选股大赛$$$$$$
CLDX 怎么瀑布到5块多了?推荐一个大家都很熟悉的股票
相关话题的讨论汇总
话题: snss话题: vosaroxin话题: quarter话题: sunesis话题: march